ECT combined with BLM is not a treatment modality that can restore the apoptotic signaling pathways to eliminate the development of cancer cells.; therefore, the combination of ECT with anticancer treatments that target the apoptotic pathway, such as Bcl-2 family of proteins, p53, or IAPs, should be evaluated in further preclinical studies. This evidence concerns the gene BCL2 and cancer.